Breadcrumb Home Yale Technologies AtiasPharma: Developing New Therapeutic Agents Targeting Endocrine FCFs and their Cellular Pathways Yale Lifesciences Pitchfest 2019 12/06/2019 AtiasPharma: Developing New Therapeutic Agents Targeting Endocrine FCFs and their Cellular Pathways Investigators Joseph Schlessinger, PhD William H. Prusoff Professor of Pharmacology; Chair, Pharmacology; Co-Director, Cancer Biology Institute
Joseph Schlessinger, PhD William H. Prusoff Professor of Pharmacology; Chair, Pharmacology; Co-Director, Cancer Biology Institute
